Mixed signals for equities from the latest Commitments of Traders data issued this Friday afternoon by the U.S. Commodity Futures Trading Commission…

Flate base breakout, high probability for trend continuation…

Axentis Pharma AG (Switzerland) and aRigen Pharmaceuticals, Inc. (Japan) announced the signature of a license agreement for the development of therapy against lung infections in Cystic Fibrosis …

Evogene Ltd. announced successful third year field trial results for Evo133, one of its candidate genes for improving plant yield and tolerance to abiotic stress conditions. Transgenic tomato plants …

Researchers report new insights into how genetic variation may create phenotypic differences between individuals. This study, which investigates the influence of mutations associated with obesity on …

A clinical phase I trial of BVT.74316 has now been successfully completed. This first clinical study, with the objective to test safety and tolerability in escalating single-dose and repeated-dose …

Ablynx announced that its TNF-alpha partnership with Wyeth Pharmaceuticals has been extended for another year. Wyeth and Ablynx are collaborating to discover and develop novel Nanobody®-based …

It was another interesting day. We captured the early weakness with Put options and quickly moved to the sidelines…

The markets were very quiet today ahead of the GDP nubmers tomorrow as well as the general holiday effect as the long weekend approaches. This will be the key to watch…